Isogenica operates a range of discovery platforms supported by state-of-the-art methodologies for identifying antibody and peptide ligands.
Industries BiopharmaBiotechnologyHealth CareLife ScienceHeadquarters Regions Europe, Middle East, and Africa (EMEA) Founded Date 2000 Founders Kevin FitzGerald Operating Status Active Last Funding Type Grant
Company Type For Profit
Contact Email sales@isogenica.com Phone Number +44 1799 533680
Isogenica Limited, a biotechnology company, develops therapeutic peptides to treat diseases. The company's vitro display technology, CIS display is used to discover biologically active peptides, proteins, and antibodies. Isogenica Limited was founded in 2000 and is based in Cambridge, the United Kingdom.